Internal MedicineJan 25, 2021|3 min readBy DDNews StaffAdditional EU approvals for RINVOQThe European Commission has approved AbbVie’s RINVOQ (upadacitinib) for treatment of psoriatic arthritis and ankylosing spondylitis